Experimental models of L-DOPA-induced dyskinesia

Johnston, Tom H. and Lane, Emma Louise ORCID: https://orcid.org/0000-0001-8800-3764 2011. Experimental models of L-DOPA-induced dyskinesia. Brotchie, Jonathan, Bezard, Erwan and Jenner, Peter, eds. Pathophysiology, Pharmacology and Biochemistry of Dyskinesia, International Review of Neurobiology, vol. 98. London: Academic Press, pp. 55-93. (10.1016/B978-0-12-381328-2.00003-1)

Full text not available from this repository.

Abstract

Strategies to avoid or minimize dyskinesia and other motor complications of chronic dopamine replacement therapy in Parkinson's disease (PD) remain a significant unmet clinical need. As such, the refinement and development of animal models with which to delineate the underlying molecular mechanisms of dyskinesia and to find effective treatment paradigms remain as necessary as ever. Toxin-based models including the MPTP-lesioned primate and the 6-hydroxydopamine (6-OHDA) lesioned rodent continue to form the bedrock of current l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesia modeling approaches. This chapter reviews these models, illustrating their origins, application and strengths as well as problems that accompany their use. We also describe new methodologies that, although still in their infancy, may offer powerful future alternatives by which to better model this debilitating complication of current PD treatment.

Item Type:	Book Section
Date Type:	Publication
Status:	Published
Schools:	Schools > Pharmacy
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Uncontrolled Keywords:	Abnormal involuntary movements; MPTP-lesioned primate; 6-OHDA lesioned rat; Ahorea; Dystonia
Publisher:	Academic Press
ISBN:	9780123813282
Last Modified:	18 Oct 2022 13:37
URI:	https://orca.cardiff.ac.uk/id/eprint/14636

Citation Data

Cited 3 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item